Fungi are used industrially to obtain a variety of products, from low value bulk chemicals to high value drugs like, immunosuppressants, antibiotics, alkaloids and statins.
Lovastatin and compactin are natural statins produced as secondary metabolites by predominantly Aspergillus and Penicillium species, following a polyketide pathway. Lovastatin was one of the first cholesterol-lowering drugs. Many statins are now chemically synthesised but lovastatin is still required to produce simvastatin. Apart from reducing blood cholesterol levels simvastatin causes pleotropic effects and has potential to treat various kinds of disorders including neurodegenerative disease and cancer.
Statins are drugs prescribed to reduce serum cholesterol levels.
The first statin to be approved by the FDA, lovastatin, is produced as a result of fermentation of Aspergillus terreus 
Discovery of statins

Fungal fermentation and statin production
Statins are produced as a secondary metabolite from a polyketide pathway. This pathway is regulated by polyketide synthase genes such as Lov B, lovF and LovD, that are responsible for the transcription regulation and production of these secondary metabolites 6, 7 . Statins are produced as a secondary metabolite during stress of the fungi. Acetyl Co-A acts as precursor molecule that plays an important role in bridging the primary metabolism with the secondary metabolism leading to production of various secondary metabolites such as terpenes and polyketides including statins 8, 9 .
All fungi producing lovastatin or compactin utilise the pathway shown in Figure 2 10 .
Lovastatin is commercially produced by fermentation of A. terreus and simvastatin is produced by further chemical treatment of lovastatin usually involving direct alkylation 11, 12 .
Compactin is not as effective in inhibiting HMGCR as lovastatin, however, a semisynthetic derivative of compactin, pravastatin, is highly effective in lowering blood cholesterol levels. Different strategies have been adopted for the efficient and economic scale up of these metabolites, such as media optimisation, using cheap raw substrates, mutagenesis and bioreactor optimisation 3 .
In Focus
Unlike simvastatin where conversion of lovastatin to simvastatin is a chemical reaction, the reaction for pravastatin synthesis is bio- In our studies a new species of A. terreus, MS-7, was isolated from agricultural soils. Its identity was confirmed by ITS sequence analysis and it was found to be the potent producer of lovastatin as determined by analytical HPLC. Fermentation on modified soybean meal media resulted in more lovastatin produced using SSF (13.9 mg/g) in comparison to SmF (10.3 mg/g). As lovastatin produced by the fungus is inhibitory, production by SSF might result in minimal contact of mycelia with the lovastatin underneath, enhancing the productivity. Another factor that can result in greater production is that SSF promotes more mycelial growth as compared to the SmF.
Application of statins
The mevalonate pathway is not only responsible for the synthesis of Statins also reduce hepatic cholesterols leading to reduced gallstone formation and reduced platelet aggregation 20, 21 . Recent studies have reported the role of statins in cognitive impairment after sepsis by reversing the microvascular dysfunction and reducing neuroinflammation 22 . Simvastatin has been found to reduce the incidence of neurodegenerative disorders such as Alzheimer's disease and Parkinson's disease 23 .
